Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform
Applied DNA Sciences, Inc. (APDN)
Last applied dna sciences, inc. earnings: 8/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adnas.com/molecular-based-security/investors
Company Research
Source: Business Wire
Demonstrates Growing Interest and Demand for Alternatives to Plasmids as Source of DNA in Pre-Clinical Therapeutic Applications STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN, Applied DNA, “the Company”) announced today that LineaRx, Inc., its majority-owned subsidiary focused on next-generation biotherapeutics and diagnostics, has grown its customer base to fourteen companies currently testing its linear DNA manufacturing platform for the development of nucleic acid-based therapies and diagnostics. The Company believes this expansion is indicative of an increasing need for an alternative to plasmids as the source of DNA.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191125005217/en/(Graphic: Business Wire)Applied DNA’s therapeutic and diagnostic client/partner base has grown to fourteen companies developing a variety of therapeutic indications including gene therapies, DNA vaccines against
Show less
Read more
Impact Snapshot
Event Time:
APDN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APDN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APDN alerts
High impacting Applied DNA Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
APDN
News
- Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private PlacementAccesswire
- Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 [Yahoo! Finance]Yahoo! Finance
- Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16Accesswire
- Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement Accesswire
- Applied DNA Sciences, Inc. (NASDAQ: APDN) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
APDN
Earnings
- 8/8/24 - Beat
APDN
Sec Filings
- 10/31/24 - Form 424B5
- 10/31/24 - Form 8-K
- 10/2/24 - Form SC
- APDN's page on the SEC website